Mar 11, 2019 - Allergan’s recent failure with Rapastinel adds to the company’s woes. However, there is a portion of the investor community that remains believers in Allergan’s underlying value.These investors see va
Mar 01, 2019 - Revance Therapeutics Inc (RVNC) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: RVNC, release date:Mar 01, 2019
Feb 26, 2019 - Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2018 Earnings Conference Call February 26, 2019 4:30 PM ET Company Participants Jeanie Herbert - Senior Director of Investor Relations and Corporate Communi
Feb 26, 2019 - RVNC earnings call for the period ending December 31, 2018.
Feb 05, 2019 - Allergan's (AGN) stock declines almost 4% after FDA approves Evolus' Jeuveau injection to treat frown lines, which can pose strong competition to Botox.
Jan 16, 2019 -
Dec 05, 2018 - Shares have risen by just 5% since my initial article and lost a quarter of their value since my last update.I provide a recap of the bullish thesis and recent events.SAKURA phase 3 open-label data wa
Nov 01, 2018 - Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2018 Earnings Conference Call November 1, 2018, 16:30 ET Executives Jeanie Herbert - Senior Director of IR & Corporate Communications Daniel Browne - Co
Sep 10, 2018 - Revance is a clinical-stage biotechnology company focused on the development and commercialization of botulinum toxin (Botox) products for cosmetic and therapeutic applications.Near-term catalysts inc
Jul 17, 2018 - Revance Therapeutics Sees Hammer Chart Pattern: Time to Buy?